OS Therapies Inc, 2026-01-20
An SEC Form D private-offering notice from Grasonville, MD, a $7,531,884 filer-stated offering target in Biotech. Filed 2026-01-20. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical stage cancer immunotherapy company developing OST HER2 and an antibody drug conjugate platform to treat osteosarcoma and other HER2 expressing solid tumors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Strydent Autonomous Technologies, Inc., 2026-01-29, Dayton, MD
- Cantai Therapeutics, Inc., 2026-01-21, $3M, Philadelpia, PA
- TradeVector Inc., 2026-01-22, $500K, Edgewater, MD
- Kaida BioPharma Inc., 2026-01-21, $4.1M, Fort Lauderdale, FL
- Inventwood Inc., 2026-01-20, $15M, College Park, MD
- TwoStep Therapeutics, Inc., 2026-01-20, $62.2M, San Carlos, CA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.